Aditxt Purchases AiPharma Global
AiPharma holds the exclusive rights to Avigan and all formulations of Favipiravir, a drug targeting Covid-19.
Stay updated with breaking news from Aipharma Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AiPharma holds the exclusive rights to Avigan and all formulations of Favipiravir, a drug targeting Covid-19.
Aditxt Signs Share Exchange Agreement to Acquire AiPharma - read this article along with other careers information, tips and advice on BioSpace
The drug acts by inhibiting SARS-CoV-2 from replicating in the human system - News - PharmaTimes
The drug acts by inhibiting SARS-CoV-2 from replicating in the human system - News - PharmaTimes
Data from the Government's Covid dashboard suggest the latest surge in infections peaked last Thursday, when there were just over 44,000 in a day.